Edited by veteran analyst Robert Morris, Biotech Supertrader is a trading research service that focuses solely on stocks in the biotech sector.  The trades are designed to take full advantage of the explosive nature of these particular stocks.

Many of the recommendations will be based around FDA decisions, clinical trials, and scientific journal data.  History has shown that trading biotech stocks in this fashion offers the potential for gains of 500% all the way up to 5,000% within a relatively short amount of time. 

Methodology

The methodology behind Biotechnology Supertrader involves first having a solid fundamental basis for the trade.  We're looking for revolutionary stocks that have drugs, treatments, and testing equipment designed to combat all kinds of illnesses that plague mankind.

Once a few potential candidates are discovered, Robert applies his proprietary screens and analysis to narrow down his list to only those stocks that have the immediate potential for enormous profit.

It is only after rigorous research and analysis that Robert makes a recommendation to his subscribers.  Once he does, an email is immediately sent to his subscribers that gives them all the information they need to make a quick decision.  He tells you what he's recommending, why it's about to move, how much you should pay for it, and what dates to keep an eye on.

Once a recommendation is made, Robert will keep you constantly updated about not only the positions in the portfolio, but also the biotech sector in general.  You’ll get ongoing market commentary as well specific suggestions on how to manage the trades.

And when it's time to exit a position, Robert will send an email sell alert with clear instructions on when to sell and at what price.

Meet the Editor

As mentioned earlier, Biotech Supertrader is written by noted analyst Robert Morris.  Before coming to Hyperion Financial, Robert worked for a number of Wall Street firms such as Salomon Smith Barney, UBS and Charles Schwab.

Prior to that Robert used his law degree from George Washington University to advise small companies on a number of important issues. It's this broad, and unique perspective that gives Robert an edge in discovering tomorrow's 'next big thing' in the biotech sector- an area he's had considerable success in.

Robert also contributes as a guest editor to the very popular investment letter, the Dynamic Wealth Report.

What’s Included With A Subscription

Your subscription to Biotech Supertrader includes 1-2 trade alerts sent out each month as opportunities arise.  Each one will include a explosive biotech stock with immediate potential for substantial gain.

In addition, you'll get frequent updates that keep you informed on your positions and the biotech sector in general.  If something happens to one of your stocks, you'll hear about it right away!

Further, as part of the service, Robert will issue specific, and timely sell alerts so you know EXACTLY when to take profits, and when to dump losers.  That way, you'll never be left in the dark about your open positions.

Biotech Supertrader subscribers also get 7 day a week, 24 hour access to the members section of this website.  Here subscribers have access to current recommendations, the trade archive, position updates, the track record and any special reports we publish.

Additionally, new subscribers receive the "Biotech Supertrader Operating Manual" as well as our popular guide "Biotechnology Investing 101".  These reports describe in greater detail how the service works and how to use Biotech Supertrader for maximum profit.

To learn more, click here.